LUCD
Lucid Diagnostics Inc.
NASDAQ · Healthcare · Medical - Devices · US
$0.43
+5.03%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 6.38x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 7.55x
- Price / sales
- 15.16x
- Price / cash flow
- -1.76x
Enterprise value
- Enterprise value
- $74.1M
- EV / sales
- 13.60x
- EV / EBITDA
- -1.44x
- EV / EBIT
- -1.46x
- Market cap
- $82.5M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026